The Washington AIDS Partnership recently received its first ever grant from the M·A·C AIDS Fund, $50,000 to increase syringe access in the District of Columbia. The grant will support the Partnership’s Syringe Access Working Group (SAWG), a dynamic collaboration between
- the Washington AIDS Partnership
- Drug Policy Alliance
- Whitman-Walker Clinic
- Prevention Works
- DC Appleseed Center
…and the group’s federal advocacy partners:
- the District’s HIV/AIDS Administration
- AIDS Action
- Hogan and Hartson LLP
- Human Rights Campaign
- Gay and Lesbian Activists Alliance
The goal of the SAWG is for every injection drug user in the District of Columbia to have access to sterile syringes and ancillary services such as HIV counseling and testing, drug treatment referrals, and case management. Approximately one third of new AIDS cases are attributed to injection drug use in the District. Access to clean syringes as part of a comprehensive prevention and treatment program has been proven to be an effective HIV prevention strategy.
Established in 1994 by M·A·C Cosmetics, the M·A·C AIDS Fund supports men, women and children affected by HIV/AIDS. Introducing its first VIVA GLAM lipstick that same year, M·A·C decided that every cent of the selling price of the VIVA GLAM lipsticks would go to the M·A·C AIDS Fund. Over $95 million has been raised to date to help those affected by HIV/AIDS.